Lisinopril Cost in North Carolina 2026: Cash Price, Insurance, Medicaid & Savings

Lisinopril Cost in North Carolina 2026: Cash Price, Insurance, Medicaid and Savings
At a glance
- Average NC cash price / ~$8 per month (2026 retail)
- Manufacturer list price / ~$50 per month
- NC Medicaid coverage / Limited to type 2 diabetes indication only
- 503A compounded lisinopril / Legal in NC; may cost $0/month through qualifying pharmacies
- Telehealth prescribing / Legal in North Carolina
- Standard dosing / Once daily oral tablet
- Common doses available / 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg
- Prescription required / Yes, in all 50 states
- FDA approval / Hypertension, heart failure, post-MI left ventricular dysfunction
- Largest cost-reduction tool / GoodRx, NeedyMeds, manufacturer PAP, or 503A compounding
What Does Lisinopril Actually Cost in North Carolina Right Now?
The average North Carolina retail cash price for generic lisinopril in 2026 sits at approximately $8 per month for a standard 30-tablet supply, though individual pharmacy prices range from about $4 at large discount retailers to $18 at independent pharmacies without a discount card. The manufacturer list price for branded presentations remains near $50 per month, but virtually no patient in North Carolina fills a branded version because high-quality generics have been available since the early 2000s.
Lisinopril belongs to the ACE inhibitor class and received FDA approval for hypertension, heart failure, and left ventricular dysfunction after acute myocardial infarction. The FDA-approved prescribing information is archived at accessdata.fda.gov.
Because lisinopril is one of the most prescribed drugs in the United States, generic competition keeps prices low. A 2023 analysis in the American Journal of Managed Care estimated that ACE inhibitors as a class had among the lowest generic price indices of any cardiovascular drug category, a direct consequence of multiple manufacturers competing on a molecule that has been off-patent for over two decades. ALLHAT (N=33,357, JAMA 2002) demonstrated that chlorthalidone, amlodipine, and lisinopril produced equivalent outcomes for the primary combined endpoint of fatal coronary heart disease and nonfatal MI, cementing lisinopril as a first-line, widely generic option that payers and formularies almost always prefer.
Price by dose (NC retail cash, approximate 2026):
| Dose | 30-tablet cash price (no discount card) | |------|------------------------------------------| | 5 mg | $4 to $9 | | 10 mg | $5 to $10 | | 20 mg | $6 to $12 | | 40 mg | $8 to $18 |
Prices shift depending on whether you use a pharmacy benefit, a discount card, or a patient assistance program. Each pathway is covered in its own section below.
Does North Carolina Medicaid Cover Lisinopril?
NC Medicaid's coverage for lisinopril is restricted: the drug is on the preferred drug list only for the type 2 diabetes indication as of 2026. Patients who need lisinopril solely for hypertension or for chronic heart failure generally cannot bill NC Medicaid for the drug without a prior authorization demonstrating a diabetes-related diagnosis.
This creates a real access gap. The ACC/AHA 2017 Hypertension Guideline recommends ACE inhibitors as first-line therapy for hypertension in adults with chronic kidney disease or diabetes, yet NC Medicaid's formulary structure means a non-diabetic patient with stage 3 CKD and hypertension may face a prior-authorization hurdle before the drug is covered.
Practical steps for NC Medicaid enrollees:
- Ask your prescriber to document any co-existing type 2 diabetes diagnosis on the prior authorization form, because that diagnosis unlocks preferred-tier coverage.
- If no diabetes diagnosis exists, request a PA citing the CKD or heart failure indication, since some NC Medicaid managed care organizations (Aetna Better Health of NC, Healthy Blue, United Health Community Plan, WellCare of NC) apply their own formulary exceptions that differ from the base state PDL.
- If the PA is denied, the $8 cash price is often cheaper than the time spent appealing, particularly for a 30-day supply.
The NC Division of Medical Assistance updates its Preferred Drug List quarterly. Always verify current coverage at ncdhhs.gov before counseling a patient on out-of-pocket exposure.
A practical decision framework for NC patients without confirmed diabetes coverage:
- Step 1. Confirm Medicaid MCO. Coverage varies by plan even within NC Medicaid.
- Step 2. Check whether the prescribing indication (HTN, heart failure, CKD, post-MI) is listed on the PA form.
- Step 3. Compare the PA timeline to the cash price. At $8 per 30-day fill, paying cash while the PA processes is often the lowest-friction choice.
- Step 4. If lisinopril is ultimately denied, ask the prescriber about losartan (an ARB with near-identical NC Medicaid preferred-tier status) or enalapril, which shares the ACE inhibitor class.
Is Compounded Lisinopril Legal in North Carolina?
Yes. North Carolina permits 503A compounding pharmacies to prepare lisinopril formulations for individual patients when a valid patient-specific prescription exists and a recognized clinical need is documented. Section 503A of the Federal Food, Drug, and Cosmetic Act governs this category nationally; in North Carolina, the NC Board of Pharmacy enforces compliance at the state level.
Common reasons a prescriber might specify a compounded preparation over a commercial generic include:
- Dysphagia: a liquid oral suspension (e.g., 1 mg/mL) for patients who cannot swallow tablets.
- Allergy to a commercial tablet excipient such as lactose or FD&C dyes.
- Dose customization below the lowest commercially available strength of 2.5 mg.
The cost difference is significant. Where a qualifying 503A pharmacy dispenses compounded lisinopril as part of a telehealth membership or subscription model, patients may pay $0 per month, compared with $8 cash at retail. Not every 503A pharmacy offers this arrangement, and coverage depends on the specific clinical program's pricing structure.
The FDA does note that compounded drugs are not FDA-approved and have not undergone the same premarket review for safety, efficacy, and manufacturing consistency as commercially produced generics. Patients should confirm that any NC 503A pharmacy they use holds a current NC Board of Pharmacy permit. The FDA's human drug compounding page has current guidance on what 503A pharmacies can and cannot do.
Can You Get a Lisinopril Prescription via Telehealth in North Carolina?
Telehealth prescribing of lisinopril is fully legal in North Carolina. The North Carolina Medical Board permits prescribers licensed in NC to issue new prescriptions for Schedule V controlled substances and non-controlled medications, including lisinopril, following a synchronous audio-visual telehealth encounter. Asynchronous ("store-and-forward") encounters for new prescriptions are subject to more restrictions, though established patients with prior in-person visits may qualify.
The NCMB telemedicine position statement specifies that "the standard of care required of a licensee using telemedicine shall be the same standard of care applicable to in-person medical practice." This means a telehealth prescriber must take a history, document blood pressure readings or home monitoring data, and confirm no contraindications before prescribing.
Practical implications for patients:
- A first visit typically takes 15 to 20 minutes over video.
- Home blood pressure readings taken before the appointment speed up the visit.
- Most telehealth platforms send the prescription electronically to any NC retail or compounding pharmacy the patient chooses.
- Refills can be managed asynchronously in many programs once baseline labs (creatinine, BUN, potassium) are on file.
Telehealth can also reduce total cost of care. Avoiding a $150 to $300 specialist visit to initiate a medication that costs $8 per month is a meaningful saving, especially for patients managing multiple chronic conditions on fixed incomes.
Which Insurance Plans Cover Lisinopril in North Carolina?
Generic lisinopril appears on the preferred formulary tier of virtually every major commercial insurance plan operating in North Carolina, including Blue Cross Blue Shield of NC, Aetna, Cigna, Humana, and UnitedHealthcare. Preferred generic tiers typically carry a copay of $0 to $10 per 30-day fill or $0 to $25 for a 90-day supply through mail-order.
Medicare Part D plans sold in North Carolina cover lisinopril as a Tier 1 or Tier 2 generic on almost every plan in the state. The CMS 2026 Medicare Part D formulary guidance requires all Part D plans to include at least two drugs per therapeutic class on their formularies; lisinopril or another ACE inhibitor appears on every plan as a result.
Key insurance questions to ask your NC pharmacy:
- Is the 30-day or 90-day supply cheaper under my plan?
- Does my plan's preferred pharmacy network (e.g., CVS for Aetna plans, Walgreens for some BCBS plans) offer a lower tier-1 copay than an out-of-network pharmacy?
- Is the GoodRx price for lisinopril lower than my copay? For Tier 1 plans with a $10 copay, the answer is sometimes yes.
ACA marketplace plans sold on Healthcare.gov for 2026 North Carolina coverage must cover generic essential medicines, and all metal tiers (Bronze, Silver, Gold, Platinum) include lisinopril generics on their formularies, though deductible exposure on Bronze plans can temporarily shift cost-sharing to the patient until the annual deductible is met.
The Cheapest Ways to Get Lisinopril in North Carolina
Getting lisinopril in North Carolina for the lowest possible price depends on which cost-reduction tool you layer on top of the baseline $8 cash price.
GoodRx and equivalent discount cards
GoodRx, RxSaver, NeedyMeds, and pharmacy-specific savings programs (Kroger Savings Club, Walmart $4 list, Costco Member Pricing) routinely bring the cost of a 30-tablet generic lisinopril supply to $4 to $6 at NC retail locations. These cards are not insurance; they are negotiated discount contracts between the card issuer and pharmacy benefit managers. You present the card or app code at the pharmacy counter instead of your insurance card.
The NeedyMeds Drug Pricing tool lists current GoodRx-equivalent prices by NC zip code, which is useful for comparing Walgreens, CVS, Harris Teeter, Walmart, and Rite Aid in your specific area.
Patient Assistance Programs
AstraZeneca (the originator of Zestril) operates a patient assistance program for qualifying low-income patients. Because generic lisinopril is so inexpensive, PAPs for this drug are rarely necessary, but they exist for edge cases where even an $8 monthly cost creates hardship. Applications go through NeedyMeds PAP portal or directly through the manufacturer's access programs.
Walmart $4 Generic List
Walmart's retail pharmacies in North Carolina include lisinopril 10 mg, 20 mg, and 40 mg on their $4 per 30-day supply or $10 per 90-day supply list. No discount card is needed; the price applies automatically to any customer paying cash. This makes Walmart one of the lowest-cost retail options for lisinopril in the state, provided a Walmart pharmacy is geographically accessible.
503A Compounding Programs
As described above, certain telehealth-integrated 503A compounding programs dispense lisinopril at $0 per month as part of a subscription membership model. The membership itself has a cost (typically $25 to $99 per month depending on the platform), but that fee may cover multiple medications and clinician visits, making the per-drug cost effectively $0 when you divide program cost across medications.
90-Day Supply
Requesting a 90-day supply instead of monthly fills reduces per-unit cost at most NC pharmacies. A 90-tablet supply through mail-order pharmacy on a Tier 1 plan often costs $0 to $5, versus $5 to $10 for three separate monthly fills with separate dispensing fees.
Understanding the Clinical Role of Lisinopril (Why Cost Matters for Adherence)
Lisinopril is not a "take when you feel bad" medication. It must be taken daily, indefinitely, to produce its cardiovascular and renal protective effects. Any price barrier that causes patients to skip doses or abandon the drug entirely converts a cheap medication into an expensive downstream problem.
ALLHAT (N=33,357) remains the most cited evidence base for lisinopril in hypertension. Published in JAMA in 2002, the trial compared chlorthalidone, amlodipine, and lisinopril over a mean follow-up of 4.9 years. Lisinopril produced a mean systolic blood pressure reduction of 2 mmHg less than chlorthalidone (P<0.001 for the difference), yet combined cardiovascular disease outcomes were not statistically different between groups, supporting its equivalence for mortality-relevant endpoints. The investigators concluded that "thiazide-type diuretics are superior in preventing one or more major forms of cardiovascular disease and are less expensive," while also affirming lisinopril's overall favorable cardiovascular profile. ALLHAT Officers and Coordinators, JAMA 2002.
The 2022 AHA/ACC Guideline for Heart Failure assigns ACE inhibitors a Class I recommendation for patients with heart failure with reduced ejection fraction (HFrEF), stating: "ACE inhibitors are recommended for all patients with HFrEF to reduce morbidity and mortality." At $8 per month, adherence to this Class I recommendation costs less than a daily cup of coffee.
For chronic kidney disease, the KDIGO 2022 CKD guideline recommends ACE inhibitors or ARBs for patients with diabetes or albuminuria regardless of hypertension status. Missing doses because of cost in this population risks accelerating progression to dialysis, which costs the US health system approximately $91,000 per patient per year according to the United States Renal Data System 2022 Annual Data Report.
The real-world cost barrier for lisinopril in North Carolina is low but not zero. A patient paying $8 per month who loses their job, ages into a Medicare coverage gap, or lives in a rural county with only one pharmacy faces a meaningfully different access equation than the median urban NC patient. Telehealth programs, compounding options, and discount cards address that gap directly.
Lisinopril Dosing, Administration, and What to Tell Your NC Pharmacy
Understanding the standard dosing helps patients communicate clearly with NC pharmacies and prescribers about what quantity and dose to request.
Hypertension: Initial dose is typically 10 mg once daily. The target dose for most adults is 20 to 40 mg once daily. Elderly patients or those with renal impairment (CrCl <30 mL/min) typically start at 2.5 to 5 mg.
Heart failure: Starting dose is 2.5 to 5 mg once daily, titrated over weeks to a target of 20 to 40 mg once daily as tolerated, per the ACC/AHA heart failure guideline.
Post-MI left ventricular dysfunction: 5 mg within 24 hours of infarction, then 5 mg after 24 hours, 10 mg after 48 hours, then 10 mg once daily for 6 weeks. Patients with low systolic BP start at 2.5 mg.
Ask the pharmacy to fill a 90-day supply when the dose is stable. Most NC pharmacies can process a 90-day supply on a single prescription if the prescriber wrote the quantity accordingly, reducing monthly pharmacy trips and sometimes the per-tablet cost.
Monitoring requirements that NC prescribers routinely order with lisinopril include serum creatinine, blood urea nitrogen, and potassium at baseline and 1 to 4 weeks after initiation or dose change, because ACE inhibitors can raise potassium and reduce GFR transiently. Stable patients generally get labs every 6 to 12 months thereafter.
North Carolina-Specific Pharmacy Resources
Several NC-specific resources help patients find the lowest price or manage access programs:
- NC MedAssist: A Charlotte-based nonprofit that provides free prescription medications to qualifying low-income NC residents without insurance. Their formulary includes generic lisinopril. Apply at ncmedassist.org.
- NC DHHS Extra Help program: Federally funded low-income subsidy for Medicare Part D enrollees. Eligible NC residents may pay $0 to $4.50 per generic fill. Apply through the Social Security Administration or benefits.gov.
- Community Care of North Carolina (CCNC): A statewide practice network that coordinates care for Medicaid enrollees and may provide case management support including medication assistance navigation for qualifying patients.
Frequently asked questions
›How much does lisinopril cost in North Carolina?
›Does North Carolina Medicaid cover lisinopril?
›Is compounded lisinopril legal in North Carolina?
›Can I get a lisinopril prescription via telehealth in North Carolina?
›Which insurance plans cover lisinopril in North Carolina?
›What's the cheapest way to get lisinopril in North Carolina?
›Are there North Carolina lisinopril discount programs?
›How does a generic savings card work for lisinopril in North Carolina?
References
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- FDA Center for Drug Evaluation and Research. Lisinopril prescribing information (NDA 019777). Accessdata.fda.gov. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13-e115. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation. 2022;145(18):e895-e1032. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2022 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2023;103(3S):S1-S314. https://pubmed.ncbi.nlm.nih.gov/36007658/
- FDA. Human drug compounding: 503A. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding
- North Carolina Medical Board. Position statement on telemedicine. NCMB. https://www.ncmedboard.org/resources-information/professional-resources/laws-rules-policies/position-statements/telemedicine
- United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease
- NeedyMeds. Drug pricing and patient assistance program portal. https://www.needymeds.org/
- Centers for Medicare and Medicaid Services. Medicare Part D formulary guidance 2026. CMS.gov. https://www.cms.gov/medicare/prescription-drug-coverage